The week in industry: NovaBiotics receive £1.8 million to advance antifungal drug candidate
This week: The Royal Osteoporosis Society will be launching a new academy to find a cure for osteoporosis, a report has shown that new medicines entering the market in 2016 and 2017 was dominated by high-cost medicines and the US FDA gives orphan drug designation to Biohaven Pharmaceutical’s (CT, USA) verdiperstat.
Please sign in or register for FREE
Sign in to RxNet
Not yet a member? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Future Medicinal Chemistry FREE
- Receive a weekly email roundup of the latest news and expert opinions
Did you know?
Your RxNet account also gives you access to communities on regenerative medicine, real-world evidence and 3D printing in medicine. Find out more>>